Prescription Drug and Health Care Spending Reporting Requirements for Health Plans and Insurers Under the CAA-21 | Practical Law
A Practice Note addressing statutory requirements for group health plans and health insurers regarding prescription drug and health care spending under the Consolidated Appropriations Act, 2021 (CAA-21). The CAA-21 reporting requirements were the topic of implementing interim final regulations (IFRs) (addressed in this resource) that were issued by the federal administrative agencies in November 2021.